Yoshimi Imura

Is platelet activating factor (PAF) a mediator of endotoxin shock?

Zen‐ichi Terashita, Yoshimi Imura, Kohei Nishikawa et al. · European Journal of Pharmacology · 1985 · 247 citations

Inflammation, Thrombosis, Thrombopoiesis +9

In Vitro Antagonistic Properties of a New Angiotensin Type 1 Receptor Blocker, Azilsartan, in Receptor Binding and Function Studies

Mami Ojima, Hideki Igata, Masayuki Tanaka et al. · Journal of Pharmacology and Experimental Therapeutics · 2010 · 146 citations

Identification of Benzoxazin-3-one Derivatives as Novel, Potent, and Selective Nonsteroidal Mineralocorticoid Receptor Antagonists

Tomoaki Hasui, Nobuyuki Matsunaga, Taiichi Ora et al. · Journal of Medicinal Chemistry · 2011 · 109 citations · Full text

Combinatorial Chemistry, Crystal Structure, Medicinal Chemistry +13

Inhibition by CV-3988 of the binding of [3H]-platelet activating factor (PAF) to the platelet

Zen‐ichi Terashita, Yoshimi Imura, Kohei Nishikawa · Biochemical Pharmacology · 1985 · 105 citations

Inflammation, Thrombosis, Thrombopoiesis +13

Comparing myotoxic effects of squalene synthase inhibitor, T-91485, and 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors in human myocytes

Tomoyuki Nishimoto, Ryuichi Tozawa, Yuichiro Amano et al. · Biochemical Pharmacology · 2003 · 75 citations

Human Myocytes, Biochemistry, Medicine +10